Amneal Pharmaceuticals, Inc. (AMRX) shareholders
Close on Nov 17, 2026Market cap $6.74BP/E 43.1Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Tushar Patel | 61,341,678 | 17.60% | 13D (active) amendment | Aug 10, 2026 |
| Patel Tushar Bhikhubhai | 48,578,209 | 15.70% | 13D (active) amendment | Mar 14, 2025 |
| Chintu Patel | 32,576,528 | 9.40% | 13D (active) amendment | Aug 10, 2026 |
| Chirag Patel | 29,097,645 | 8.40% | 13D (active) amendment | Aug 10, 2026 |
| Patel Chintu | 25,910,032 | 8.20% | 13D (active) amendment | Oct 3, 2025 |
| BlackRock, Inc. | 24,121,119 | 7.60% | 13G (passive) | Mar 31, 2026 |
| Patel Chirag K. | 22,180,421 | 7.10% | 13D (active) amendment | Aug 6, 2025 |
| Akram Mahesh | 20,558,759 | 6.56% | 13G (passive) amendment | Mar 31, 2025 |
| Patel Dipan | 16,904,263 | 5.40% | 13D (active) amendment | Dec 31, 2025 |
| UBS Group AG | – | – | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AMRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 26,562,093 | 8.32% | $459.79M | +2,042,901 | 0.01% |
| Tpg Gp A, LLC | 12,328,767 | 3.86% | $213.41M | – | 4.27% |
| Vanguard Portfolio Management LLC | 12,137,727 | 3.80% | $210.10M | +812,794 | 0.01% |
| Rubric Capital Management LP | 10,168,660 | 3.18% | $176.02M | −868,929 | 1.61% |
| Vanguard Capital Management LLC | 7,710,126 | 2.41% | $133.46M | +125,092 | 0.00% |
| State Street Corp | 7,356,977 | 2.30% | $127.35M | +562,275 | 0.00% |
| Dimensional Fund Advisors LP | 5,794,263 | 1.81% | $100.30M | +103,677 | 0.02% |
| Geode Capital Management, LLC | 5,139,449 | 1.61% | $88.98M | +593,401 | 0.00% |
| Assenagon Asset Management S.A. | 4,891,098 | 1.53% | $84.66M | +1,823,737 | 0.05% |
| Nantahala Capital Management, LLC | 4,537,502 | 1.42% | $78.54M | +1,693,394 | 1.30% |
| Morgan Stanley | 4,110,028 | 1.29% | $71.14M | −527,157 | 0.00% |
| Neuberger Berman Group LLC | 3,887,179 | 1.22% | $67.28M | +204,895 | 0.04% |
| Invesco Ltd. | 3,502,000 | 1.10% | $60.62M | +313,341 | 0.00% |
| Nuveen, LLC | 3,324,875 | 1.04% | $57.55M | +81,232 | 0.01% |
| Allspring Global Investments Holdings, LLC | 3,295,533 | 1.03% | $55.93M | +745,961 | 0.09% |
| Goldman Sachs Group Inc | 3,013,961 | 0.94% | $52.17M | +150,101 | 0.00% |
| Charles Schwab Investment Management Inc | 2,147,450 | 0.67% | $37.17M | −36,711 | 0.00% |
| Northern Trust Corp | 1,914,895 | 0.60% | $33.15M | +208,788 | 0.00% |
| Acadian Asset Management LLC | 1,650,255 | 0.52% | $28.56M | −281,639 | 0.03% |
| Ameriprise Financial Inc | 1,581,869 | 0.50% | $27.39M | −283,332 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 308 | 168M | 52.7% | 47 / 138 | 83 / 52 | 18M | 11M |
| Q1 2026 | 317 | 161M | 50.4% | 79 / 116 | 78 / 36 | 48M | 24M |
| Q4 2025 | 278 | 155M | 48.5% | 57 / 101 | 80 / 24 | 17M | 13M |
| Q3 2025 | 248 | 152M | 47.5% | 39 / 97 | 73 / 30 | 17M | 9M |
| Q2 2025 | 241 | 144M | 45.2% | 34 / 104 | 60 / 29 | 21M | 13M |
| Q1 2025 | 237 | 136M | 42.5% | 53 / 92 | 53 / 14 | 16M | 4M |
| Q4 2024 | 199 | 126M | 39.5% | 41 / 87 | 41 / 22 | 10M | 27M |
| Q3 2024 | 183 | 144M | 45.1% | 27 / 64 | 59 / 25 | 26M | 13M |
| Q2 2024 | 182 | 142M | 44.4% | 36 / 71 | 44 / 29 | 47M | 16M |
| Q1 2024 | 176 | 110M | 34.6% | 31 / 67 | 49 / 7 | 14M | 16M |
| Q4 2023 | 153 | 112M | 35.2% | 34 / 52 | 44 / 25 | 19M | 8M |
| Q3 2023 | 144 | 102M | 31.9% | 32 / 54 | 32 / 15 | 11M | 6M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
294 funds held AMRX in Q2 2026, 66% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of AMRX | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 10,379,876 | 3.25% | $179.68M | 0.16% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 5,555,668 | 1.74% | $96.17M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 4,383,877 | 1.37% | $75.88M | 0.09% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 4,029,125 | 1.26% | $69.74M | 0.04% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 2,549,077 | 0.80% | $44.12M | 0.07% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,973,859 | 0.62% | $34.17M | 0.03% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,863,299 | 0.58% | $34.14M | 0.10% | Jul 31, 2026 |
| Invesco S&P SmallCap Momentum ETF | 1,844,564 | 0.58% | $33.79M | 1.11% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 1,585,224 | 0.50% | $27.44M | 0.16% | Jun 30, 2026 |
| U.S. Small Cap Portfolio | 1,235,443 | 0.39% | $22.63M | 0.11% | Jul 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 1,196,688 | 0.37% | $20.71M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 1,194,290 | 0.37% | $20.67M | 0.14% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 1,070,643 | 0.34% | $19.61M | 0.13% | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 1,001,761 | 0.31% | $18.35M | 0.23% | Jul 31, 2026 |
| Columbia Small Cap Value and Inflection Fund | 979,518 | 0.31% | $12.90M | 1.49% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Chintu Patel | Co-CEO, Director | 32,523,507 | 10.18% | Aug 12, 2026 |
| Chirag K. Patel | President & Co-CEO, Director | 29,044,624 | 9.09% | Aug 12, 2026 |
| Andrew S. Boyer | Executive Vice President | 193,646 | 0.06% | Sep 2, 2026 |
| Nikita Shah | Executive Vice President | 253,390 | 0.08% | Aug 13, 2026 |
| Jason B. Daly | EVP, Chief Legal Officer | 35,171 | 0.01% | Aug 13, 2026 |
| Tasos Konidaris | Executive Vice President & CFO | 449,434 | 0.14% | Mar 5, 2026 |
| J. Kevin Buchi | Director | 189,021 | 0.06% | Sep 21, 2026 |
| John Kiely | Director | 200,252 | 0.06% | Aug 14, 2026 |
| Gautam Patel | Director | 1,927,595 | 0.60% | Aug 12, 2026 |
| Deborah M. Autor | Director | 93,660 | 0.03% | May 12, 2026 |
| Ted C. Nark | Director | 325,848 | 0.10% | May 8, 2026 |
| Paul M. Meister | Director | 832,800 | 0.26% | May 8, 2026 |
| Shlomo Yanai | Director | 320,804 | 0.10% | May 8, 2026 |
| Jeffrey P. George | Director | 344,614 | 0.11% | May 8, 2026 |
| Emily Peterson Alva | Director | 211,029 | 0.07% | May 8, 2025 |
| Tushar Bhikhubhai Patel | 10% owner | 61,341,678 | 19.21% | Aug 12, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| J. Kevin Buchi Director | Sep 17, 2026 | Gift | −20,445 | – | – | 75,077 |
| J. Kevin Buchi Director | Sep 11, 2026 | Option exercise | +20,445 | $14.45 | $295.43K | 95,522 |
| Andrew S. Boyer Executive Vice President | Sep 1, 2026 | Gift | −80,000 | – | – | 193,646 |
| Andrew S. Boyer Executive Vice President | Aug 21, 2026 | Gift | −152,426 | – | – | 273,646 |
| John Kiely Director | Aug 13, 2026 | Gift | −10,000 | – | – | 200,252 |
| John Kiely Director | Aug 13, 2026 | Sale | −50,000 | $17.64 | $882.00K | 210,252 |
| Jason B. Daly EVP, Chief Legal Officer | Aug 12, 2026 | Sale | −210,000 | $17.40 | $3.65M | 35,171 |
| Nikita Shah Executive Vice President | Aug 12, 2026 | Sale | −146,403 | $17.51 | $2.56M | 253,390 |
| J. Kevin Buchi Director | Aug 11, 2026 | Option exercise | −168,573 | $17.18 | $2.90M | 93,499 |
| Jason B. Daly EVP, Chief Legal Officer | Aug 11, 2026 | Sale | −6,613 | $17.70 | $117.05K | 245,171 |
| Chintu Patel Co-CEO, Director | Aug 10, 2026 | Award | +6,381,734 | – | – | 6,381,734 |
| Chirag K. Patel President & Co-CEO, Director | Aug 10, 2026 | Award | +6,381,734 | – | – | 6,381,734 |
| Gautam Patel Director | Aug 10, 2026 | Award | +283,632 | – | – | 283,632 |
| Tushar Bhikhubhai Patel 10% owner | Aug 10, 2026 | Award | +12,763,469 | – | – | 61,341,678 |
| Deborah M. Autor Director | May 11, 2026 | Sale | −34,819 | $12.94 | $450.56K | 93,660 |
| John Kiely Director | May 7, 2026 | Option exercise | +34,819 | – | – | 260,252 |
| Deborah M. Autor Director | May 7, 2026 | Option exercise | +34,819 | – | – | 128,479 |
| J. Kevin Buchi Director | May 7, 2026 | Option exercise | +34,819 | – | – | 75,077 |
| Paul M. Meister Director | May 7, 2026 | Option exercise | +48,747 | – | – | 832,800 |
| Jeffrey P. George Director | May 7, 2026 | Option exercise | +34,819 | – | – | 344,614 |
| Ted C. Nark Director | May 7, 2026 | Option exercise | +34,819 | – | – | 325,848 |
| Gautam Patel Director | May 7, 2026 | Option exercise | +34,819 | – | – | 1,643,963 |
| Shlomo Yanai Director | May 7, 2026 | Option exercise | +34,819 | – | – | 320,804 |
| Chintu Patel Co-CEO, Director | Mar 4, 2026 | Option exercise | +92,593 | – | – | 1,417,504 |
| Chintu Patel Co-CEO, Director | Mar 4, 2026 | Tax withholding | −28,983 | $13.30 | $385.47K | 1,388,521 |
| Nikita Shah Executive Vice President | Mar 4, 2026 | Tax withholding | −17,976 | $13.30 | $239.08K | 399,793 |
| Nikita Shah Executive Vice President | Mar 4, 2026 | Option exercise | +35,880 | – | – | 417,769 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 4, 2026 | Option exercise | +35,880 | – | – | 267,364 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 4, 2026 | Tax withholding | −15,580 | $13.30 | $207.21K | 251,784 |
| Tasos Konidaris Executive Vice President & CFO | Mar 4, 2026 | Tax withholding | −22,035 | $13.30 | $293.07K | 449,434 |
| Tasos Konidaris Executive Vice President & CFO | Mar 4, 2026 | Option exercise | +43,982 | – | – | 471,469 |
| Chirag K. Patel President & Co-CEO, Director | Mar 4, 2026 | Tax withholding | −37,825 | $13.30 | $503.07K | 1,393,470 |
| Chirag K. Patel President & Co-CEO, Director | Mar 4, 2026 | Option exercise | +92,593 | – | – | 1,431,295 |
| Andrew S. Boyer Executive Vice President | Mar 4, 2026 | Option exercise | +38,195 | – | – | 445,208 |
| Andrew S. Boyer Executive Vice President | Mar 4, 2026 | Tax withholding | −19,136 | $13.30 | $254.51K | 426,072 |
| Chintu Patel Co-CEO, Director | Mar 3, 2026 | Option exercise | +733,944 | – | – | 1,640,796 |
| Chintu Patel Co-CEO, Director | Mar 3, 2026 | Option exercise | +59,931 | – | – | 923,964 |
| Chintu Patel Co-CEO, Director | Mar 3, 2026 | Tax withholding | −17,112 | $13.31 | $227.76K | 906,852 |
| Chintu Patel Co-CEO, Director | Mar 3, 2026 | Tax withholding | −315,885 | $13.31 | $4.20M | 1,324,911 |
| Nikita Shah Executive Vice President | Mar 3, 2026 | Option exercise | +36,232 | – | – | 182,635 |
| Nikita Shah Executive Vice President | Mar 3, 2026 | Tax withholding | −18,502 | $13.31 | $246.26K | 164,133 |
| Nikita Shah Executive Vice President | Mar 3, 2026 | Option exercise | +45,871 | – | – | 210,004 |
| Nikita Shah Executive Vice President | Mar 3, 2026 | Tax withholding | −22,982 | $13.31 | $305.89K | 187,022 |
| Nikita Shah Executive Vice President | Mar 3, 2026 | Option exercise | +23,544 | – | – | 210,566 |
| Nikita Shah Executive Vice President | Mar 3, 2026 | Tax withholding | −11,796 | $13.31 | $157.00K | 198,770 |
| Nikita Shah Executive Vice President | Mar 3, 2026 | Option exercise | +366,972 | – | – | 565,742 |
| Nikita Shah Executive Vice President | Mar 3, 2026 | Tax withholding | −183,853 | $13.31 | $2.45M | 381,889 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 3, 2026 | Tax withholding | −10,533 | $13.31 | $140.19K | 58,457 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 3, 2026 | Tax withholding | −10,147 | $13.31 | $135.06K | 23,104 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 3, 2026 | Option exercise | +38,226 | – | – | 61,330 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 3, 2026 | Tax withholding | −16,598 | $13.31 | $220.92K | 44,732 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 3, 2026 | Option exercise | +24,258 | – | – | 68,990 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 3, 2026 | Option exercise | +22,645 | – | – | 33,251 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 3, 2026 | Option exercise | +305,810 | – | – | 364,267 |
| Jason B. Daly EVP, Chief Legal Officer | Mar 3, 2026 | Tax withholding | −132,783 | $13.31 | $1.77M | 231,484 |
| Tasos Konidaris Executive Vice President & CFO | Mar 3, 2026 | Option exercise | +458,716 | – | – | 657,304 |
| Tasos Konidaris Executive Vice President & CFO | Mar 3, 2026 | Option exercise | +45,290 | – | – | 167,442 |
| Tasos Konidaris Executive Vice President & CFO | Mar 3, 2026 | Tax withholding | −229,817 | $13.31 | $3.06M | 427,487 |
| Tasos Konidaris Executive Vice President & CFO | Mar 3, 2026 | Tax withholding | −14,298 | $13.31 | $190.31K | 198,588 |
| Tasos Konidaris Executive Vice President & CFO | Mar 3, 2026 | Option exercise | +28,538 | – | – | 212,886 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Amneal Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 90,162 shares on Sep 8, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| John Kiely Director | Aug 13, 2026 | 50,000 | $879.71K | Aug 13, 2026 | EQUITY COMPENSATION |
| Jason B. Daly OFFICER | Aug 12, 2026 | 210,000 | $3.65M | Aug 11, 2026 | EQUITY COMPENSATION |
| Nikita Shah Officer | Aug 12, 2026 | 146,403 | $2.56M | Aug 12, 2026 | EQUITY COMPENSATION |
| J. Kevin Buchi Director | Aug 11, 2026 | 168,573 | $2.92M | Aug 11, 2026 | Restricted Stock Award |
| Deborah M. Autor DIRECTOR | May 11, 2026 | 34,819 | $450.42K | May 11, 2026 | EQUITY COMPENSATION |
| Ted C. Nark Director | Nov 17, 2025 | 50,000 | $591.25K | Nov 17, 2025 | Open Market Purchase |
| Nikita Shah OFFICER | Nov 12, 2025 | 131,856 | $1.57M | Nov 12, 2025 | STOCK OPTION EXERCISE |
| John Kiely Director | Aug 27, 2025 | 32,000 | $293.81K | Aug 27, 2025 | EQUITY COMPENSATION |
| Nikita Shah Officer | Aug 22, 2025 | 36,796 | $356.92K | Aug 22, 2025 | EQUITY COMPENSATION |
| Nikita Shah Officer | Aug 22, 2025 | 84,036 | $818.93K | Aug 22, 2025 | Executive Compensation |
| Andrew S. Boyer Officer | Aug 20, 2025 | 104,244 | $969.47K | Aug 20, 2025 | Restricted Stock Award |
| Andrew S. Boyer Officer | Aug 20, 2025 | 175,000 | $1.64M | Aug 20, 2025 | STOCK OPTIONS |
| Tasos Konidaris Officer | Aug 15, 2025 | 219,159 | $2.06M | Aug 15, 2025 | RSU Vesting |
| Nikita Shah Officer | Aug 14, 2025 | 71,694 | $663.07K | Aug 14, 2025 | EQUITY COMPENSATION |
| Tasos Konidaris Officer | Aug 13, 2025 | 169,206 | $1.57M | Aug 13, 2025 | RSU Vesting |
See a number that looks wrong?